Cronos Group Inc. splits its revenue into 3 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Cannabis Flower at $48.0 million, 76% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
206
|
63
|
53
|
45
|
45
|
36
|
33
|
32
|
30
|
| Cannabis Flower |
155
+57.6%
share 75.0%
|
48
+82.0%
share 75.6%
|
39
+56.7%
share 74.0%
|
34
+44.5%
share 74.6%
|
34
+44.2%
share 75.8%
|
26
share 72.5%
|
25
share 74.8%
|
23
share 72.4%
|
23
share 77.2%
|
| Cannabis Extracts |
51
+53.5%
share 25.0%
|
15
+55.1%
share 24.4%
|
14
+64.8%
share 26.0%
|
11
+33.1%
share 25.3%
|
11
+63.4%
share 24.2%
|
10
share 27.4%
|
8
share 25.0%
|
9
share 26.7%
|
7
share 21.7%
|
| Product And Service Other |
0
-90.7%
share 0.0%
|
0
-23.1%
share 0.0%
|
0
-72.9%
share 0.0%
|
0
-93.9%
share 0.0%
|
0
-94.3%
share 0.0%
|
0
share 0.0%
|
0
share 0.2%
|
0
share 1.0%
|
0
share 1.0%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CRON (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Stayner, Ontario, Canada
- SEC filer status
- Accelerated filer
- SEC CIK
- 1656472
- Former names
- PharmaCan Capital Corp. (until May 27, 2016)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.